Today

Agents

Chat

Arena

Discover

More

App

Phio Pharma wins US, Canada patent allowances for INTASYL siRNA compounds - PHIO News | Rallies

Phio Pharma wins US, Canada patent allowances for INTASYL siRNA compounds

PHIO•2026-07-15

Patent allowances in US, Canada and Japan

Phio Pharmaceuticals reported three notices of allowance in the US and Canada for patents covering INTASYL siRNA compounds.

A separate patent grant decision was received in Japan, strengthening protection for the same INTASYL technology.

Phio’s global patent portfolio totals 54 issued patents spanning INTASYL chemistry, gene targets, and immuno-oncology indications.

Related News

Citigroup <C.N>: Argus Research raises target price to $150 from $145

Tanger declares quarterly dividend of $0.31 a share payable Aug. 14

SKT•2026-07-15

European wheat rallies to one-year high on escalating Black Sea attacks

2026-07-15

Evercore updates financial calendar with upcoming Q2 results conference call

EVR•2026-07-15

Sandisk Corp <SNDK.O>: Argus Research initiates coverage with hold rating

SNDK•2026-07-15